Verastem | VSTM - Trade Creditors


Verastem reported $9.89M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
AstraZeneca USD 25.28B 252M Dec/2025
Curis USD 4.1M 1.01M Jun/2025
Cytokinetics USD 105.62M 83.53M Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
Incyte USD 1.63B 1.46B Dec/2025
Laboratory Of America USD 840.8M 172.3M Dec/2025
Novartis USD 4.56B 49M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025
Verastem USD 9.89M 2.69M Sep/2025